News & Announcements

(Statement) The Medicines Patent Pool Welcomes Extension of MPP-Gilead HIV Licences to Include Belarus, Malaysia and Ukraine

(Statement) The Medicines Patent Pool Welcomes First Generic Dolutegravir-Combination to Receive Tentative Approval from U.S. Food and Drug Administration

Bristol-Myers Squibb, Medicines Patent Pool Extend Licence for Atazanavir to 122 Developing Countries

Upcoming events

MPP Symposium at the 48th Union World Conference on Lung Health – Friday 13 October at 14h00

More information

Recent Highlights

The Medicines Patent Pool Adds Three New Partners to Generic Network

Read more

MPP statement on addressing the global shortage of, and access to, medicines and vaccines

Read the full statement

MPP statement on the evaluation and review of the Global Strategy and Plan of Action on Public Health, Innovation and IP

Read the full statement

Debate at the World Health Assembly: Delivering Appropriate Treatment to Low- and Middle-Income Countries

Read the MPP Executive Director’s message

MPP statement on Antimicrobial resistance at the 70th World Health Assembly

Read the full statement